Matrix Asset Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Matrix Asset Advisors's LLY Position: Q3 2026 in Review
Matrix Asset Advisors reduced its Eli Lilly (LLY) stake by 1.9% in Q3 2026, selling an estimated $7.08K and leaving 305 shares worth $352K. The position accounts for 0.03% of the portfolio, ranked #84.
Matrix Asset Advisors first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $372K in Q2 2026. 1,134 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Matrix Asset Advisors held 305 shares of Eli Lilly worth $352K as of Q3 2026.
- Matrix Asset Advisors sold 6 Eli Lilly shares in Q3 2026, an estimated $7.08K.
- Eli Lilly made up 0.03% of Matrix Asset Advisors's portfolio in Q3 2026, its #84 holding.
- Matrix Asset Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
- Matrix Asset Advisors's Eli Lilly position peaked at $372K in Q2 2026.
- 1,134 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Matrix Asset Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.